Cipla
New developments from Cipla outlined recently
Published in Health Business Week, April 13th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Cipla.
Report 1: Country's second-biggest drug maker Cipla, which slashed prices of generic AIDS drugs internationally, is soon to champion another global move to contain malaria.
The company has entered into a development and supply agreement with Drugs for Neglected Diseases Initiative (DNDi), a global non-profit organisation, for a new anti-malarial combination drug. The drug, a new fixed dose combination of artesunate and mefloquine, will be manufactured by Cipla using the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2007-04-13)
More Articles from Health Business Week
- AARP
AARP Teams With Iowa Business, Industry, Education and Labor to Spur Action on Health Care, Long-Term Financial Security - Abbott
Abbott Named to DiversityInc's 'Top 50 Companies for Diversity' List - Abiomed, Inc.
Abiomed Expands Availability of Impella Circulatory Support Technologies with Regulatory Approvals in India - Abiomed, Inc.
Abiomed, Inc. Closes Sale of Common Stock in Public Offering - Achillion Pharmaceuticals, Inc.
Achillion Reports 2006 Fourth Quarter and Year-End Financial Results - Acne Vulgaris
CollaGenex Pharmaceuticals Initiates 40 mg Cohort in the Phase II Dose-Finding Study of Incyclinide for the Treatment of Acne - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
